Reuters Breakingviews says Syngenta IPO may be overvalued
A Reuters Breakingviews headline comments on Syngenta’s IPO valuation; the supplied text provides no supporting details.
Story updates
12:01:34 PM UTC
SquawkNews
By Ka Sing ChanInvestors mulling whether to take part in Syngenta's IPO may want to reach for their pruning shears first. The Switzerland-based seeds-to-pesticides firm bought nine years ago by ChemChina is eyeing a market valuation of between $66 billion and $88 billion, Reuters reported on Tuesda…